Clinical Trials
3 trialsNCT06940804 2025-07-02
AVENTURINE
BioNTech SE
Phase 2 Withdrawn
NCT02300987 2020-10-26
A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression
Novartis
Phase 2 Completed
NCT00611962 2008-02-11
Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin
Sanofi
Phase 2 Completed